https://clotconnect.org/md/2023-07-04T14:35:24+00:00weekly0.6https://clotconnect.org/dvt-material/https://clotconnect.org/wp-content/uploads/2023/07/spa1-1.jpgspa1-1https://clotconnect.org/wp-content/uploads/2023/07/eng1-2.jpgeng1-2https://clotconnect.org/wp-content/uploads/2020/03/basics-2.jpgbasics 2https://clotconnect.org/wp-content/uploads/2020/03/the-basics.jpgthe basicshttps://clotconnect.org/wp-content/uploads/2020/03/pateint-guide-snip.jpgpateint guide snip2023-07-04T14:17:59+00:00weekly0.6https://clotconnect.org/newly-diagnosed/https://clotconnect.org/wp-content/uploads/2020/03/dvtpehandoutimage-process-s225x340.pngDVTPEhandoutimage-process-s225x3402023-07-04T14:06:25+00:00weekly0.6https://clotconnect.org/patient-resources/2023-05-26T20:48:13+00:00weekly0.6https://clotconnect.org/list-of-posts/2023-05-26T20:46:56+00:00weekly0.6https://clotconnect.org/blog-posts/2023-05-26T20:39:25+00:00weekly0.6https://clotconnect.org/2020/05/04/prescription-affordability-assistance-options-for-anticoagulants/2023-04-04T15:48:47+00:00monthlyhttps://clotconnect.org/2011/06/22/starting-pradaxa-checklist-2/2023-04-04T15:48:44+00:00monthlyhttps://clotconnect.org/2011/06/23/eliquis-apixaban-good-news/2023-04-04T15:48:44+00:00monthlyhttps://clotconnect.org/2011/02/02/progestin-only-contraceptives-and-thrombosis/2023-04-04T15:48:44+00:00monthlyhttps://clotconnect.org/2011/02/02/family-member-testing-for-thrombophilia/2023-04-04T15:48:44+00:00monthlyhttps://clotconnect.org/2011/07/01/xarelto-rivaroxaban-fda-approved-good-news/2023-04-04T15:48:44+00:00monthlyhttps://clotconnect.org/2011/01/31/dental-work-on-warfarin-2/2023-04-04T15:48:44+00:00monthlyhttps://clotconnect.org/2011/01/31/unexplained-arterial-thrombosis-causes-thrombophilia-testing/2023-04-04T15:48:44+00:00monthlyhttps://clotconnect.org/2011/01/28/inrs-that-fluctuate-solutions/2023-04-04T15:48:44+00:00monthlyhttps://clotconnect.org/2011/02/14/hit-heparin-induced-thrombocytopenia-2/2023-04-04T15:48:44+00:00monthlyhttps://clotconnect.org/2011/01/24/arm-and-leg-veins-anatomy-terminology/2023-04-04T15:48:44+00:00monthlyhttps://clotconnect.org/2011/01/12/xarelto-good-news-2/2023-04-04T15:48:44+00:00monthlyhttps://clotconnect.org/2011/01/12/xarelto-good-news/2023-04-04T15:48:44+00:00monthlyhttps://clotconnect.org/2011/06/22/starting-pradaxa-checklist/2023-04-04T15:48:44+00:00monthlyhttps://clotconnect.org/2011/02/12/cerebral-venous-thrombosis/2023-04-04T15:48:44+00:00monthlyhttps://clotconnect.org/2011/03/18/apixaban-eliquis-another-new-oral-blood-thinner/2023-04-04T15:48:44+00:00monthlyhttps://clotconnect.org/2011/03/23/hair-loss-on-warfarin-2/2023-04-04T15:48:44+00:00monthlyhttps://clotconnect.org/2011/03/03/athletes-and-dvt-pe/2023-04-04T15:48:44+00:00monthlyhttps://clotconnect.org/2011/03/31/dvt-and-pe-how-long-to-treat-with-anticoagulants/2023-04-04T15:48:44+00:00monthlyhttps://clotconnect.org/2011/03/01/testosterone-and-thrombosis/2023-04-04T15:48:44+00:00monthlyhttps://clotconnect.org/2011/04/14/pradaxa-interruption-for-colonoscopy-dental-procedures-surgery-etc/2023-04-04T15:48:44+00:00monthlyhttps://clotconnect.org/2011/04/14/pradaxa-interruption-for-colonoscopies-dental-procedures-surgery-etc/2023-04-04T15:48:44+00:00monthlyhttps://clotconnect.org/2011/04/21/incidentally-discovered-dvt-pe-or-other-clots/2023-04-04T15:48:44+00:00monthlyhttps://clotconnect.org/2011/06/29/pulmonary-hypertension-after-pe-cteph/2023-04-04T15:48:44+00:00monthlyhttps://clotconnect.org/2011/05/30/pregnancy-loss-and-thrombophilia/2023-04-04T15:48:44+00:00monthlyhttps://clotconnect.org/2011/06/15/protein-c-deficiency/2023-04-04T15:48:44+00:00monthlyhttps://clotconnect.org/2011/06/16/protein-c-deficiency-2/2023-04-04T15:48:44+00:00monthlyhttps://clotconnect.org/2011/02/13/dvt-and-pe-symptoms-and-risk-factors/2023-04-04T15:48:44+00:00monthlyhttps://clotconnect.org/2010/12/06/pradaxa-management-of-major-bleeding-2/2023-04-04T15:48:44+00:00monthlyhttps://clotconnect.org/education-materials/2023-04-04T15:48:44+00:00weekly0.6https://clotconnect.org/is-it-normal-to-be-anxious-or-depressed-after-a-clot/2023-04-04T15:48:44+00:00weekly0.6https://clotconnect.org/how-soon-after-a-clot-can-i-fly/2023-04-04T15:48:44+00:00weekly0.6https://clotconnect.org/how-long-after-my-clot-can-i-resume-physical-activities/2023-04-04T15:48:44+00:00weekly0.6https://clotconnect.org/when-will-my-clot-and-pain-go-away/2023-04-04T15:48:44+00:00weekly0.6https://clotconnect.org/2010/11/12/update-the-clot-connect-project/2023-04-04T15:48:44+00:00monthlyhttps://clotconnect.org/faq/2023-04-04T15:48:44+00:00weekly0.6https://clotconnect.org/2011/09/26/yasmin-yaz-angeliq-and-risk-for-blood-clots/2023-04-04T15:48:44+00:00monthlyhttps://clotconnect.org/2011/07/08/postpartum-safe-birth-control-choices/2023-04-04T15:48:44+00:00monthlyhttps://clotconnect.org/how-long-do-i-need-to-be-treated-with-a-blood-thinner-anticoagulant/2023-04-04T15:48:44+00:00weekly0.6https://clotconnect.org/2011/09/18/nattokinase-2/2023-04-04T15:48:44+00:00monthlyhttps://clotconnect.org/2011/02/25/acute-proximal-dvt-offering-patients-enrollment-into-attract-trial/2023-04-04T15:48:44+00:00monthlyhttps://clotconnect.org/2010/11/25/heavy-menstrual-bleeds-on-anticoagulants-treatment-options/2023-04-04T15:48:44+00:00monthlyhttps://clotconnect.org/2010/11/23/pradaxa-approval-great-news/2023-04-04T15:48:44+00:00monthlyhttps://clotconnect.org/2011/03/01/hht-2/2023-04-04T15:48:43+00:00monthlyhttps://clotconnect.org/2020/12/29/covid-19-vaccination-while-on-a-blood-thinner/2020-12-29T23:41:47+00:00monthlyhttps://clotconnect.org/2020/04/18/for-health-care-professionals-preventing-thrombosis-in-covid-19-anticoagulation-algorithm/2020-09-16T10:00:25+00:00monthlyhttps://clotconnect.org/2020/04/28/coumadin-discontinuation-of-sale/https://clotconnect.org/wp-content/uploads/2023/04/b9f8b-bms1.jpgbms12020-04-28T16:52:53+00:00monthlyhttps://clotconnect.org/2020/03/30/coronavirus-for-patients/2020-03-30T16:58:43+00:00monthlyhttps://clotconnect.org/2013/05/01/natural-supplements-herbs-vitamins-and-food-do-any-prevent-venous-thromboembolism/2020-03-28T16:12:41+00:00monthlyhttps://clotconnect.org/2020/03/26/covid-19-and-coagulopathy-two-management-guidance-documents-for-health-care-professionals/2020-03-27T14:26:46+00:00monthlyhttps://clotconnect.org/2020/03/25/use-of-eliquis-and-xarelto-after-gastric-banding-or-other-weight-loss-surgery/2020-03-27T13:35:31+00:00monthlyhttps://clotconnect.org/2020/03/21/new-oral-anticoagulant-fda-approved-bevyxxa-betrixaban/2020-03-27T13:35:27+00:00monthlyhttps://clotconnect.org/2011/10/12/blood-or-organ-donation-the-patient-on-anticoagulants-or-with-thrombophillia/2020-03-27T13:29:07+00:00monthlyhttps://clotconnect.org/2011/10/12/blood-or-organ-donation-being-on-blood-thinners-or-having-a-thrombophilia/2020-03-27T13:29:04+00:00monthlyhttps://clotconnect.org/2011/09/30/hip-and-knee-replacement-dvt-prevention-new-guideline/2020-03-27T13:28:56+00:00monthlyhttps://clotconnect.org/2011/09/30/hip-and-knee-replacement-surgery-dvt-prophylaxis-aaos-guideline/2020-03-27T13:28:51+00:00monthlyhttps://clotconnect.org/2011/09/26/yasmin-yaz-and-other-drospirenone-contraceptives-risk-for-vte/2020-03-27T13:28:43+00:00monthlyhttps://clotconnect.org/2011/09/23/fondaparinux-arixtra-generic-2/2020-03-27T13:28:30+00:00monthlyhttps://clotconnect.org/2011/09/23/fondaparinux-arixtra-generic/2020-03-27T13:28:25+00:00monthlyhttps://clotconnect.org/2011/09/18/nattokinase/2020-03-27T13:28:15+00:00monthlyhttps://clotconnect.org/2011/09/08/rivaroxaban-xarelto-advisory-board-to-the-fda-recommends-approval-for-atrial-fibrillation/2020-03-27T13:28:05+00:00monthlyhttps://clotconnect.org/2011/09/06/rivaroxaban-xarelto-fda-recommends-against-approval-for-atrial-fibrillation/2020-03-27T13:27:59+00:00monthlyhttps://clotconnect.org/2011/09/02/minor-cut-bleeding-and-nosebleeds-on-anticoagulants/2020-03-27T13:27:52+00:00monthlyhttps://clotconnect.org/2011/09/02/minor-cuts-and-bleeding-on-blood-thinners-2/2020-03-27T13:27:49+00:00monthlyhttps://clotconnect.org/2011/08/28/apixaban-eliquis-plus-update-on-new-oral-anticoagulants/2020-03-27T13:27:40+00:00monthlyhttps://clotconnect.org/2011/08/28/eliquis-apixaban-news-plus-update-on-the-big-four-new-oral-anticoagulants/2020-03-27T13:27:35+00:00monthlyhttps://clotconnect.org/2011/08/24/pregnancy-and-blood-clots-prevention-diagnosis-treatment/2020-03-27T13:27:24+00:00monthlyhttps://clotconnect.org/2011/08/24/pregnancy-and-venous-thromboembolism-prevention-diagnosis-treatment/2020-03-27T13:27:18+00:00monthlyhttps://clotconnect.org/2011/08/17/being-on-blood-thinners-how-do-i-know-i-am-bleeding/2020-03-27T13:27:14+00:00monthlyhttps://clotconnect.org/2011/08/17/tattoos-on-anticoagulants/2020-03-27T13:27:08+00:00monthlyhttps://clotconnect.org/2011/08/10/thrombophilia-and-insurance-2/2020-03-27T13:26:50+00:00monthlyhttps://clotconnect.org/2011/08/10/thrombophilia-and-insurance/2020-03-27T13:26:44+00:00monthlyhttps://clotconnect.org/2011/08/03/prescription-assistance-when-patients-cant-afford-their-anticoagulant/2020-03-27T13:26:39+00:00monthlyhttps://clotconnect.org/2011/08/03/prescription-assistance-when-patients-cant-afford-a-medication/2020-03-27T13:26:04+00:00monthlyhttps://clotconnect.org/2011/07/28/thrombosis-and-hemostasis-conference-2012/2020-03-27T13:25:59+00:00monthlyhttps://clotconnect.org/2011/07/28/north-american-meeting-on-clotting-and-bleeding/2020-03-27T13:25:41+00:00monthlyhttps://clotconnect.org/2011/07/21/dvt-long-term-damage-post-thrombotic-syndrome/https://clotconnect.org/wp-content/uploads/2011/07/pts.jpgPostthrombotic syndorme of right leg with leg hyperpigementation2020-03-27T13:25:37+00:00monthlyhttps://clotconnect.org/2011/07/20/lixiana-edoxaban-new-oral-blood-thinner/2020-03-27T13:25:22+00:00monthlyhttps://clotconnect.org/2011/07/20/lixiana-edoxaban-new-oral-anticoagulant/2020-03-27T13:25:15+00:00monthlyhttps://clotconnect.org/2011/07/13/lmwh-injections-making-it-easier-insuflon-ports/2020-03-27T13:25:10+00:00monthlyhttps://clotconnect.org/2011/07/13/injection-of-blood-thinners-under-the-skin-making-it-easier-insuflon-ports/2020-03-27T13:25:06+00:00monthlyhttps://clotconnect.org/2011/07/08/postpartum-safe-contraceptive-methods/2020-03-27T13:24:58+00:00monthlyhttps://clotconnect.org/2011/07/01/xarelto-rivaroxaban-fda-approved/2020-03-27T13:24:47+00:00monthlyhttps://clotconnect.org/2011/06/29/chronic-lung-damage-after-pe-pulmonary-hypertension-cteph/2020-03-27T13:24:30+00:00monthlyhttps://clotconnect.org/2011/06/23/eliquis-apixaban-good-news-2/2020-03-27T13:24:22+00:00monthlyhttps://clotconnect.org/2011/05/30/pregnancy-loss-and-clotting-disorders/2020-03-27T13:22:36+00:00monthlyhttps://clotconnect.org/2011/05/24/coumadin-clinics-finding-one-near-you/2020-03-27T13:22:26+00:00monthlyhttps://clotconnect.org/2011/04/26/pradaxa-what-your-physicianhospital-wants-to-know/2020-03-27T13:21:59+00:00monthlyhttps://clotconnect.org/2011/05/24/anticoagulation-clinics-finding-one-for-your-patient/2020-03-27T13:20:53+00:00monthlyhttps://clotconnect.org/2011/04/26/pradaxa-dabigatran-hospital-guideline/2020-03-27T13:20:31+00:00monthlyhttps://clotconnect.org/2011/04/21/incidentally-discovered-blood-clots/2020-03-27T13:20:20+00:00monthlyhttps://clotconnect.org/2011/03/29/warfarin-induced-skin-necrosis-2/2020-03-27T13:19:36+00:00monthlyhttps://clotconnect.org/2011/03/29/warfarin-induced-skin-necrosis/https://clotconnect.org/wp-content/uploads/2011/03/paulo-warfarinsk2.jpgpaulo.warfarinskWarfarin-induced skin necrosis. Breast appearance 7 days, 4 weeks, and 2 and 6 months after start of warfarin. On day +5 wafarin was stopped and replaced by heparin.https://clotconnect.org/wp-content/uploads/2011/03/paulo-warfarinsk1.jpgpaulo.warfarinskWarfarin-induced skin necrosis. Breast appearance 7 days, 4 weeks, and 2 and 6 months after start of warfarin. On day +5 wafarin was stopped and replaced by heparin.https://clotconnect.org/wp-content/uploads/2011/03/paulo-warfarinsk.jpgpaulo.warfarinskhttps://clotconnect.org/wp-content/uploads/2011/03/slide1.jpgSlide12020-03-27T13:19:27+00:00monthlyhttps://clotconnect.org/2011/03/29/purple-toe-syndrome-2/2020-03-27T13:19:20+00:00monthlyhttps://clotconnect.org/2011/03/29/purple-toe-syndrome/https://clotconnect.org/wp-content/uploads/2011/03/moll-image-6-purple-toe1.jpgOLYMPUS DIGITAL CAMERAPurple toe syndrome in a patient, 5 weeks after having started warfarinhttps://clotconnect.org/wp-content/uploads/2011/03/moll-image-6-purple-toe.jpgOLYMPUS DIGITAL CAMERA2020-03-27T13:19:16+00:00monthlyhttps://clotconnect.org/2011/03/28/low-molecular-weight-heparins-osteoporosis-2/2020-03-27T13:18:50+00:00monthlyhttps://clotconnect.org/2011/03/28/low-molecular-weight-heparins-osteoporosis/2020-03-27T13:18:44+00:00monthlyhttps://clotconnect.org/2011/03/23/hair-loss-on-warfarin/2020-03-27T13:18:29+00:00monthlyhttps://clotconnect.org/2011/03/18/apixaban-eliquis-another-new-oral-anticoagulant/2020-03-27T13:18:23+00:00monthlyhttps://clotconnect.org/2011/03/04/what-causes-clots-a-family-study/2020-03-27T13:18:12+00:00monthlyhttps://clotconnect.org/2011/03/02/athletes-and-blood-clots/https://clotconnect.org/wp-content/uploads/2011/03/arm-dvt4.jpgArm DVTImage 1. Effort Thrombosis (aka thoracic outlet syndrome). Graphic design: Jeff Harrison, Wilmington, NC. Copyright: Stephan Mollhttps://clotconnect.org/wp-content/uploads/2011/03/arm-dvt3.jpgArm DVTImage 1. Effort Thrombosis (aka thoracic outlet syndrome)https://clotconnect.org/wp-content/uploads/2011/03/arm-dvt2.jpgArm DVTImage 1. "Effort Thrombosis" (aka thoracic outlet syndrome)https://clotconnect.org/wp-content/uploads/2011/03/arm-dvt1.jpgArm DVTImage. Subclavian vein DVT in thoracic outlet syndrome (aka effort thrombosis)https://clotconnect.org/wp-content/uploads/2011/03/arm-dvt.jpgArm DVT2020-03-27T13:17:56+00:00monthlyhttps://clotconnect.org/2011/03/01/testosterone-and-blood-clots/2020-03-27T13:17:45+00:00monthlyhttps://clotconnect.org/2011/03/01/hht/2020-03-27T13:17:31+00:00monthlyhttps://clotconnect.org/2011/02/25/new-dvt-optimal-treatment-attract-trial/2020-03-27T13:17:17+00:00monthlyhttps://clotconnect.org/2011/02/14/pfo-patent-foramen-ovale-2/2020-03-27T13:17:10+00:00monthlyhttps://clotconnect.org/2011/02/14/pfo-patent-foramen-ovale/https://clotconnect.org/wp-content/uploads/2011/02/figure-2.jpgFigure 2Figure 2. DVT in a patient with PFO - leading to a paradoxical embolism, an arterial stroke. (graphic design: Jeff Harrison; Stephan Moll)https://clotconnect.org/wp-content/uploads/2011/02/figure-1.jpgFigure 1Figure 1. DVT and PE, no PFO present (Graphic design: Jeff Harrison, Wilmington, NC. Copyright Stpehan Moll).2020-03-27T13:17:06+00:00monthlyhttps://clotconnect.org/2011/02/13/hit-heparin-induced-thrombocytopenia/2020-03-27T13:16:50+00:00monthlyhttps://clotconnect.org/2011/02/11/symptoms-of-dvt-and-pe/https://clotconnect.org/wp-content/uploads/2011/02/massive-pe5.jpgMassive PEImage 3. Very alrge PE. This leads to no blood flow to the lung and to sudden death. (Graphic design Jeff Harrison; copyright Stephan Moll)https://clotconnect.org/wp-content/uploads/2011/02/massive-pe4.jpgMassive PEImage 3. Very large PE. This leads to no blood flow to the lung and to sudden death. (Graphic design: Jeff Harrison; Stephan Moll)https://clotconnect.org/wp-content/uploads/2011/02/massive-pe3.jpgMassive PEImage 4. Very large PE. This leads to no blood flow to the lung and to sudden death. (Graphic design: Jeff Harrison. Stephan Moll)https://clotconnect.org/wp-content/uploads/2011/02/massive-pe2.jpgMassive PEVery large PE. This leads to no blood flow to the lung and sudden death. (Graphic design: Jeff Harrison. Stephan Moll)https://clotconnect.org/wp-content/uploads/2011/02/massive-pe1.jpgMassive PEImage 4. Very large PE. This results in no blood flow to the lung, leading to sudden death. (Graphic design: Jeff Harrison; https://clotconnect.org/wp-content/uploads/2011/02/massive-pe.jpgMassive PEA very large PE leads to no blood flow to the lung, no oxygen uptake, resulting in sudden death. This is uncommon, but a real risk. (Graphic design: Jeff Harrison, Wilmington, NC. Stephan Moll)https://clotconnect.org/wp-content/uploads/2011/02/pe-infarct-21.jpgPE-Infarct 2PE in the left lung. The clot leads to no blood flow to that lung area, resulting in shortness of breath. The lung surface of that area gets inflammed (=pleuritis), leading to chest pain, particualrly on taking a deep breath in. (Graphic design: Jeff Harrison, Wilmington, NC. Stpehan Moll) https://clotconnect.org/wp-content/uploads/2011/02/pe-infarct-2.jpgPE-Infarct 2PE, moderately sized. in the left lung. An "infarct" is damage tissue, due to the absence of blood flow to that area. No oxygen uptake in that area of the lung is possible - therefore: shortness of breath. The surface of the lung in that area gets inflammed (=pleuritis), causing pain, particularly on taking a deep breath inl (Graphic design: Jeff harrison, Wilmington, NC. Stephan Moll)https://clotconnect.org/wp-content/uploads/2011/02/venous-clots2.jpgVenous ClotsImage 1: DVT in right leg; clot broken off the DVT and travelling in the big abdominal vein towards the lung; PE in the right lung (Graphic design Jeff Harrison, Wilmington, NC; © Stephan Moll)https://clotconnect.org/wp-content/uploads/2011/02/venous-clots1.jpgVenous ClotsImage 1: DVT in right leg; clot broken off the DVT and travelling in the big abdominal vein towards the lung; PE in the right lung (Graphic design Jeff Harrison, Wilmington, NC; © Stephan Moll)2020-03-27T13:16:23+00:00monthlyhttps://clotconnect.org/2011/02/07/sinus-and-cerebral-vein-thrombosis/https://clotconnect.org/wp-content/uploads/2011/02/image-2-thrombosis-cut.jpgimage 2 thrombosis cutImage 2. Sinus and cerebral vein thrombosis (image courtesy of Joe Chovan, medical illustrator, Cincinatti, OH)https://clotconnect.org/wp-content/uploads/2011/02/image-1-cut2.jpgimage 1 cutImage 1. Anatomy and terminology of sinus and cerebral veins (image courtesy of Joe Chovan, medical illustrator, Cincinatti, OH)https://clotconnect.org/wp-content/uploads/2011/02/image-1-cut1.jpgimage 1 cuthttps://clotconnect.org/wp-content/uploads/2011/02/image-1-cut.jpgimage 1 cuthttps://clotconnect.org/wp-content/uploads/2011/02/image-3-hemorrhage-jpeg-cut.jpgimage 3 hemorrhage JPEG cutBleeding into brain from sinus vein thrombosis (image courtesy of Joe Chovan, medical illustrator, Cincinatti, OH)https://clotconnect.org/wp-content/uploads/2011/02/image-3-jpeg.jpgImage 3 - BleedingBleeding into brain from sinus vein thrombosis2020-03-27T13:16:15+00:00monthlyhttps://clotconnect.org/2011/02/02/progestin-only-contraceptives-and-blood-clots/2020-03-27T13:16:05+00:00monthlyhttps://clotconnect.org/2011/02/02/family-member-testing-for-thrombophilia-2/2020-03-27T13:15:43+00:00monthlyhttps://clotconnect.org/2011/01/24/arm-and-leg-veins-anatomy-and-terminology/https://clotconnect.org/wp-content/uploads/2011/01/arm-vein-terminology3.jpgArm vein terminologyhttps://clotconnect.org/wp-content/uploads/2011/01/leg-vein-terminology.jpgLeg vein terminologyhttps://clotconnect.org/wp-content/uploads/2011/01/arm-vein-terminology2.jpgArm vein terminologyhttps://clotconnect.org/wp-content/uploads/2011/01/arm-vein-terminology1.jpgArm vein terminologyhttps://clotconnect.org/wp-content/uploads/2011/01/arm-vein-terminology.jpgArm vein terminologyImage 1. Arm veins2020-03-27T13:15:16+00:00monthlyhttps://clotconnect.org/2011/01/10/may-thurner-syndrome/https://clotconnect.org/wp-content/uploads/2011/01/image-21.jpgImage 2Image 2: Stenthttps://clotconnect.org/wp-content/uploads/2011/01/image-12.jpgImage 1https://clotconnect.org/wp-content/uploads/2011/01/image-2.jpgImage 2https://clotconnect.org/wp-content/uploads/2011/01/image-11.jpgImage 1https://clotconnect.org/wp-content/uploads/2011/01/image-1.jpgImage 12020-03-27T13:11:47+00:00monthlyhttps://clotconnect.org/2010/12/06/pradaxa-management-of-major-bleeding/2020-03-27T13:11:33+00:00monthlyhttps://clotconnect.org/2010/11/30/safe-pain-medications-on-warfarin/2020-03-27T13:11:24+00:00monthlyhttps://clotconnect.org/2010/11/22/long-distance-travel-and-blood-clots/2020-03-27T13:10:52+00:00monthlyhttps://clotconnect.org/2010/11/20/inrs-that-fluctuate/2020-03-27T13:10:44+00:00monthlyhttps://clotconnect.org/2010/11/19/thrombophilia-testing-who-should-be-tested/2020-03-27T13:10:38+00:00monthlyhttps://clotconnect.org/2010/11/13/unexplained-arterial-clots-causes-thrombophilia-testing/2020-03-27T13:10:27+00:00monthlyhttps://clotconnect.org/2010/11/12/dental-work-on-warfarin/2020-03-27T13:10:07+00:00monthlyhttps://clotconnect.org/2010/11/07/vitamin-e-caution-bleeding-risk/2020-03-27T13:09:54+00:00monthlyhttps://clotconnect.org/2010/11/01/warfarin-therapy-made-easier/2020-03-27T13:09:39+00:00monthlyhttps://clotconnect.org/2020/03/21/antiphospholipid-syndrome-can-the-new-oral-anticoagulants-be-used/2020-03-27T13:00:38+00:00monthlyhttps://clotconnect.org/2010/10/27/dabigatran-approval-great-news/2020-03-27T12:49:51+00:00monthlyhttps://clotconnect.org/2010/11/25/heavy-menstrual-bleeds-on-blood-thinners-what-to-do/2020-03-27T12:49:22+00:00monthlyhttps://clotconnect.org/2011/03/30/dvt-and-pe-how-long-to-treat-with-blood-thinners/2020-03-27T12:39:12+00:00monthlyhttps://clotconnect.org/about/https://clotconnect.org/wp-content/uploads/2020/03/unc_som_542.jpgUNC_SOM_5422020-03-24T19:52:51+00:00weekly0.6https://clotconnect.org/2020/03/21/acute-dvt-pe-and-airline-travel/2020-03-24T13:40:44+00:00monthlyhttps://clotconnect.org/support-clot-connect/2020-03-24T13:26:18+00:00weekly0.6https://clotconnect.org/professional-organizations/2020-03-24T12:46:27+00:00weekly0.6https://clotconnect.org/should-i-or-a-family-member-be-tested-for-thrombophilia/2020-03-24T12:31:13+00:00weekly0.6https://clotconnect.org/guidelines/2020-03-24T11:49:57+00:00weekly0.6https://clotconnect.org/athletes-and-clotting/2020-03-24T00:38:53+00:00weekly0.6https://clotconnect.org/blood-thinners-anticoagulants/2020-03-21T20:34:32+00:00weekly0.6https://clotconnect.org/support-groups/2020-03-18T14:01:00+00:00weekly0.6https://clotconnect.org/contact/2020-03-18T13:49:26+00:00weekly0.6https://clotconnect.org/2017/07/07/acute-dvt-pe-and-airline-travel-2/2017-07-07T12:20:51+00:00monthlyhttps://clotconnect.org/2017/06/30/antiphospholipid-syndrome-can-the-new-oral-anticoagulants-be-used-2/2017-06-30T15:12:13+00:00monthlyhttps://clotconnect.org/2017/06/23/new-oral-anticoagulant-fda-approved-bevyxxa-betrixaban-2/2017-06-24T00:41:14+00:00monthlyhttps://clotconnect.org/2016/10/31/athletes-and-blood-clots-2/2016-10-31T17:56:07+00:00monthlyhttps://clotconnect.org/2016/08/26/no-fda-approval-yet-for-andexanet/2016-08-26T15:18:40+00:00monthlyhttps://clotconnect.org/2016/03/30/heavier-menstrual-bleeding-on-xarelto/2016-03-30T16:15:29+00:00monthlyhttps://clotconnect.org/2016/03/30/contraceptive-use-while-on-anticoagulants-is-safe/2016-03-30T14:39:53+00:00monthlyhttps://clotconnect.org/2016/03/11/bleeding-on-antithrombotics-reversal-protocol/2016-03-12T00:41:13+00:00monthlyhttps://clotconnect.org/2016/02/18/ivc-filters-may-thurner-syndrome-pelvic-vein-stents/2016-02-18T22:48:01+00:00monthlyhttps://clotconnect.org/2016/01/18/new-comprehensive-clinical-guidance-on-vte-treatment/2016-01-19T03:12:44+00:00monthlyhttps://clotconnect.org/2016/01/08/accp-guideline-for-dvt-and-pe-treatment-new-edition/2016-01-08T23:56:31+00:00monthlyhttps://clotconnect.org/2015/07/15/scuba-diving-while-on-an-anticoagulant/2015-07-15T16:14:25+00:00monthlyhttps://clotconnect.org/2015/07/06/mthfr-and-homocysteine-information-handout-for-patients/2015-07-06T22:13:36+00:00monthlyhttps://clotconnect.org/2015/06/22/warfarin-interruption-for-surgery-bridging-with-lmwh-often-not-needed/2015-06-22T13:01:44+00:00monthlyhttps://clotconnect.org/2015/06/22/reversal-agent-for-pradaxa-important-nejm-publication-today/2015-06-22T13:01:25+00:00monthlyhttps://clotconnect.org/2015/04/01/thrombophilia-information-handout-for-patients/2015-04-01T19:57:00+00:00monthlyhttps://clotconnect.org/2015/01/27/ash-2014-highlights-thrombosis-and-anticoagulation/2015-01-28T02:34:08+00:00monthlyhttps://clotconnect.org/2015/01/08/4th-noac-fda-approved-for-dvt-pe-and-atrial-fibrillation-sayasa-edoxaban/2015-01-09T04:45:48+00:00monthlyhttps://clotconnect.org/2014/12/17/two-things-physicians-should-avoid/2014-12-17T23:42:28+00:00monthlyhttps://clotconnect.org/2014/12/09/fascinating-new-anticoagulant-it-protects-from-vte-but-does-not-increase-bleeding/2014-12-09T05:53:08+00:00monthlyhttps://clotconnect.org/2014/12/05/venous-thromboembolism-prophylaxis-in-hospitalized-patients-guidance-document/2014-12-05T23:24:44+00:00monthlyhttps://clotconnect.org/2014/11/07/antidotes-for-the-new-oral-anticoagulants-update-2/2014-11-07T19:23:43+00:00monthlyhttps://clotconnect.org/2014/09/10/xarelto-dosing-in-obese-patients/2014-09-10T19:35:33+00:00monthlyhttps://clotconnect.org/2014/08/27/aspirin-decreases-recurrent-dvt-and-pe/2014-08-27T15:17:56+00:00monthlyhttps://clotconnect.org/2014/08/22/apixaban-eliquis-fda-approval-for-dvt-and-pe-treatment/2014-08-22T15:28:08+00:00monthlyhttps://clotconnect.org/2014/06/12/is-acupuncture-safe-for-anticoagulated-patients/2014-06-12T13:29:45+00:00monthlyhttps://clotconnect.org/2014/06/11/commercial-airline-pilots-and-vte/2014-06-11T14:09:53+00:00monthlyhttps://clotconnect.org/2014/04/21/new-study-examines-psychological-impact-of-pulmonary-embolism/2014-04-21T20:19:36+00:00monthlyhttps://clotconnect.org/2014/04/07/pradaxa-dabigatran-fda-approved-for-dvt-and-pe/2014-04-07T14:33:47+00:00monthlyhttps://clotconnect.org/2014/03/01/how-long-is-the-post-partum-period-in-respect-to-thrombosis-risk/2014-03-01T16:03:57+00:00monthlyhttps://clotconnect.org/2014/02/20/1554/2014-02-21T03:32:40+00:00monthlyhttps://clotconnect.org/2014/01/23/pregnancy-breastfeeding-safety-of-various-anticoagulants/2014-01-23T13:05:40+00:00monthlyhttps://clotconnect.org/2014/01/08/moving-fast-4th-big-new-oral-anticoagulant-edoxaban-savaysa-applies-for-fda-approval/2014-01-08T21:05:48+00:00monthlyhttps://clotconnect.org/2014/01/06/fda-review-of-eliquis-apixaban-for-dvt-and-pe-treatment/2014-01-06T16:06:19+00:00monthlyhttps://clotconnect.org/2013/12/31/highlights-of-the-2013-ash-annual-meeting/2013-12-31T12:34:38+00:00monthlyhttps://clotconnect.org/2013/12/19/handout-for-your-patients-in-clinic-which-anticoagulant-to-use-for-dvt-and-pe/2013-12-19T18:46:21+00:00monthlyhttps://clotconnect.org/2013/12/18/do-compression-stockings-prevent-postthrombotic-syndrome-no/2013-12-18T21:47:16+00:00monthlyhttps://clotconnect.org/2013/12/13/reversing-warfarin-for-urgent-surgeries-fda-approval-of-kcentra/2013-12-13T23:05:30+00:00monthlyhttps://clotconnect.org/2013/12/04/three-things-we-shouldnt-do/2013-12-05T03:35:27+00:00monthlyhttps://clotconnect.org/2013/11/06/lmwh-and-epidural-catheters-fda-recommendations/2013-11-06T23:18:22+00:00monthlyhttps://clotconnect.org/2013/10/16/pulmonary-hypertension-due-to-pe-new-drug-approved/2013-10-16T23:33:40+00:00monthlyhttps://clotconnect.org/2013/10/02/major-bleeding-on-dabigatran-pradaxa-interesting-publication/2013-10-03T00:21:57+00:00monthlyhttps://clotconnect.org/2013/09/01/nejm-publication-edoxaban-for-vte-treatment/2013-09-01T17:19:24+00:00monthlyhttps://clotconnect.org/2013/08/28/new-oral-anticoagulants-for-dvt-and-pe-update-on-fda-applications/2013-08-28T17:17:32+00:00monthlyhttps://clotconnect.org/2013/07/11/international-coagulation-meeting-isth-2013-highlights/2013-07-11T23:27:08+00:00monthlyhttps://clotconnect.org/2013/07/01/new-publication-eliquis-apixaban-is-effective-and-safe-in-dvt-and-pe/2013-07-02T00:41:14+00:00monthlyhttps://clotconnect.org/2013/06/03/skyla-a-new-iud-suitable-for-women-at-risk-for-dvt-and-pe/2013-06-04T04:10:27+00:00monthlyhttps://clotconnect.org/2013/05/23/difficulty-in-diagnosing-recurrent-dvt-clinical-guidance/2013-05-24T04:04:24+00:00monthlyhttps://clotconnect.org/2013/05/17/new-clinical-practical-textbook-on-hemostasis-and-thrombosis/2013-05-18T04:31:47+00:00monthlyhttps://clotconnect.org/2013/05/08/antidote-for-new-oral-xa-inhibitors-eliquis-xarelto-phase-2-study/2013-05-09T00:55:07+00:00monthlyhttps://clotconnect.org/2013/04/29/fda-approval-of-new-drug-to-treat-major-bleeding-on-warfarin-kcentra/2013-04-30T03:50:06+00:00monthlyhttps://clotconnect.org/2013/04/22/thrombophilia-testing-reliable-on-anticoagulants/2013-04-23T04:42:40+00:00monthlyhttps://clotconnect.org/2013/03/04/warfarin-failure/2013-03-04T17:30:36+00:00monthlyhttps://clotconnect.org/2013/02/07/the-top-10-publications-on-thrombosis-in-2012/2013-02-07T18:22:41+00:00monthlyhttps://clotconnect.org/2013/02/05/apixaban-eliquis-hospital-guideline/2013-02-05T11:04:08+00:00monthlyhttps://clotconnect.org/2013/01/11/xarelto-rivaroxaban-hospital-guideline-2/2013-01-11T07:53:41+00:00monthlyhttps://clotconnect.org/2012/12/28/fda-approval-for-apixaban-eliquis-for-a-fib/2012-12-28T22:34:34+00:00monthlyhttps://clotconnect.org/2012/11/09/does-aspirin-prevent-recurrent-dvt-and-pe/2012-11-09T15:19:23+00:00monthlyhttps://clotconnect.org/2012/11/02/xarelto-rivaroxaban-fda-approved-for-dvt-and-pe-treatment/2012-11-02T22:10:30+00:00monthlyhttps://clotconnect.org/2012/10/29/ttp-secondary-to-i-v-use-of-the-pain-medication-opana-er/2012-10-29T15:12:01+00:00monthlyhttps://clotconnect.org/2012/10/24/accp-2012-guidelines-a-great-new-user-friendly-summary/2012-10-25T02:56:38+00:00monthlyhttps://clotconnect.org/2012/10/22/behind-the-headlines-does-eating-lunch-at-your-desk-increase-blood-clot-risk/2012-10-22T19:07:21+00:00monthlyhttps://clotconnect.org/2012/07/26/frequently-asked-patient-questions-when-will-my-clot-and-pain-go-away/2012-07-26T19:14:46+00:00monthlyhttps://clotconnect.org/2012/07/11/ischemic-colitis-and-thrombophilia/2012-07-11T18:06:03+00:00monthlyhttps://clotconnect.org/2012/07/06/argatroban-nomogram/2012-07-06T16:14:23+00:00monthlyhttps://clotconnect.org/2012/05/25/klippel-trenaunay-syndrome-dvt-and-pe/2012-05-26T01:22:35+00:00monthlyhttps://clotconnect.org/2012/05/23/aspirin-prevents-recurrent-dvt-and-pe/2012-05-24T03:19:07+00:00monthlyhttps://clotconnect.org/2012/05/15/which-patient-with-dvt-or-pe-to-refer-to-a-specialist/2012-05-16T04:43:39+00:00monthlyhttps://clotconnect.org/2012/05/15/recovery-after-a-dvt-or-pe/2012-05-16T03:56:44+00:00monthlyhttps://clotconnect.org/2012/05/01/compression-stockings-after-dvt/2012-05-01T22:43:15+00:00monthlyhttps://clotconnect.org/2012/03/26/rivaroxaban-xarelto-and-pe/2012-03-26T15:30:56+00:00monthlyhttps://clotconnect.org/2012/03/19/inr-self-testing/2012-03-20T03:22:15+00:00monthlyhttps://clotconnect.org/2012/02/29/dvt-in-youg-adults-ivc-abnormalities/2012-02-29T17:39:37+00:00monthlyhttps://clotconnect.org/2012/02/28/psychological-impact-of-dvt-and-pe/2012-02-28T21:47:13+00:00monthlyhttps://clotconnect.org/2012/02/27/new-accp-guidelines-dvt-and-pe-highlights-and-summary/2012-02-28T04:16:55+00:00monthlyhttps://clotconnect.org/2012/02/07/new-accp-guidelines/2012-02-07T19:50:21+00:00monthlyhttps://clotconnect.org/2012/01/31/how-often-should-the-inr-be-tested/2012-02-01T03:33:05+00:00monthlyhttps://clotconnect.org/2012/01/24/inr-patient-self-testing/2012-01-25T02:07:38+00:00monthlyhttps://clotconnect.org/2011/12/19/pradaxa-and-dvt-approved-in-europe/2012-02-02T22:05:23+00:00monthlyhttps://clotconnect.org/2011/12/13/ash-2011-highlights-in-thrombosis-and-anticoagulation/2011-12-14T03:14:01+00:00monthlyhttps://clotconnect.org/2011/12/12/aspirin-does-it-prevent-dvt-and-pe/2012-02-28T04:22:28+00:00monthlyhttps://clotconnect.org/2011/11/14/10-ways-to-communicate-better-with-your-doctor-at-your-next-office-visit/2011-11-28T16:56:22+00:00monthlyhttps://clotconnect.org/2011/10/14/blue-feet-acrocyanosis/https://clotconnect.org/wp-content/uploads/2011/10/acrocyanosis.jpgAcrocyanosis2011-11-14T15:09:11+00:00monthlyhttps://clotconnect.org/2011/11/04/another-new-blood-thinner-fda-approved-xarelto-rivaroxaban/2011-11-05T14:51:00+00:00monthlyhttps://clotconnect.org/2011/11/04/xarelto-rivaroxaban-approved-for-a-fib/2011-11-05T02:12:07+00:00monthlyhttps://clotconnect.org/2011/11/04/vte-prevention-in-hospitalized-patients-new-acp-guideline/2011-11-05T01:18:19+00:00monthlyhttps://clotconnect.org/2011/10/26/alcohol-and-warfarin/2011-11-07T15:41:14+00:00monthlyhttps://clotconnect.org/2011/10/26/alcohol-and-warfarin-2/2011-10-26T17:34:06+00:00monthlyhttps://clotconnect.org/2011/10/18/phytoestrogens-plant-estrogens-2/2011-10-18T08:48:26+00:00monthlyhttps://clotconnect.org/2011/10/18/plant-estrogens-phytoestrogens/2011-11-02T16:58:12+00:00monthlyhttps://clotconnect.org/2011/10/14/acrocyanosis/2011-10-14T20:19:32+00:00monthlyhttps://clotconnect.org/2011/08/17/tattoo-and-blood-thinners/https://clotconnect.org/wp-content/uploads/2011/08/slide13.jpgSlide1(Photo of tattoo taken and published with permission of patient)https://clotconnect.org/wp-content/uploads/2011/08/slide12.jpgSlide1https://clotconnect.org/wp-content/uploads/2011/08/slide11.jpgSlide1https://clotconnect.org/wp-content/uploads/2011/08/slide1.jpgSlide12011-11-13T03:02:56+00:00monthlyhttps://clotconnect.org/2011/01/10/may-thurner-syndrome-2/2011-03-01T21:10:50+00:00monthlyhttps://clotconnect.orgdaily1.02023-07-04T14:35:24+00:00